Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study

BACKGROUND: Percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) remains challenging even with modern drug-eluting stents (DES) due to high rates of repeat revascularization. Everolimus-eluting bioresorbable scaffolds (EE-BRS) might allow for repeat intervention prolongin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hommels, T. M., Hermanides, R. S., Rasoul, S., Berta, B., IJsselmuiden, A. J. J., Jessurun, G. A. J., Benit, E., Pereira, B., De Luca, G., Kedhi, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408833/
https://www.ncbi.nlm.nih.gov/pubmed/30851731
http://dx.doi.org/10.1186/s12933-019-0827-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408833/
https://www.ncbi.nlm.nih.gov/pubmed/30851731
http://dx.doi.org/10.1186/s12933-019-0827-z

Ejemplares similares